XuanYan Bio
玄言生物
XuanYan Bio
Biotech/Healthcare
Xuanyan Biotech has secured strategic financing worth several tens of millions of yuan from Fudan Science and Technology Innovation. The funds will be used to iterate its pan-cancer pathology AI models and advance clinical translation, consolidating its competitiveness in precision medicine.
Latest round: Strategic (2026)
Source: ChinaBulls — chinabulls.com
Last updated 2026-07-28
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.